Clinical Research Directory
Browse clinical research sites, groups, and studies.
Identifying Molecular Alterations to Guide Individualized Treatment in Advanced Solid Tumors
Sponsor: Institut Paoli-Calmettes
Summary
PERMED01 is a prospective monocenter clinical trial which aims to evaluate the number patients with locally advanced or metastatic cancer for whom identification of molecular alterations in tumor samples can lead to the delivery of a targeted therapy. PERMED01 will enroll 460 patients in 3 years.
Official title: Identifying Molecular Alterations to Guide Individualized Treatment in Advanced Solid Tumors-PERMED01-IPC 2014-003
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
550
Start Date
2014-11-12
Completion Date
2022-08-18
Last Updated
2026-04-21
Healthy Volunteers
No
Conditions
Interventions
biopsy or surgical sampling
blood sampling
Locations (1)
Institut Paoli-Calmettes
Marseille, France